Aralez Pharmaceuticals US – AstraZeneca Objects to Toprol-Xl and Vimovo Sale Orders, “Cherry-Picked” Assumption and Assignment of Contracts

October 25, 2018 – AstraZeneca AB filed an objection [Docket No. 207] to (I) the assumption, assignment, and cure amount of contracts to be assumed and assigned in the Toprol-Xl sale, (ii) to the proposed Toprol-Xl sale order and (iii) to the proposed Vimovo sale order. AstraZeneca AB explains, “Debtors seek to cherry-pick for assumption…